Cancer of endometrium - rare variant of remote metastases

Czech version

Authors: Luboš Minář; D. Petrovová; J. Kümmel
Authors‘ workplace: Gynekologicko-porodnická klinika LF MU a FN Brno, vedoucí pracoviště prof. MUDr. P. Ventruba, DrSc.
Published in: Ceska Gynekol 2009; 74(5): 383-389

Overview

Objective:
Information sheet about cancer of endometrium as the most frequently gynecological malignant tumor.

Design:
Literature review with case reports.

Setting:
Department of Gynaecology and Obstetrics, Faculty of Medicine, Masaryk’s University and Faculty Hospital, Brno.

Methods:
Literature review about cancer of endometrium with illustrative case reports.

Conclusions:
Cancer of endometrium is the most frequently malignant tumor of female reproductive organs in developed countries. Despite the absence of screening methods is almost 75% of cases diagnosed in stage I disease, which makes a good prognosis. Distant metastasis is less common, most frequently seen with a lung, but in the cencer of endoemtrium, as well as for malignant diseases in general, it is necessary to always count on is the possibility of their rare presentation. Management of cancer of endometrium is kept by oncogynecologist. Patients are divided into groups of forecasting low and high risk, while the therapeutic strategy is essential adequate radical operational solutions. In line with the trend of reduction radical solution and subsequent complications of surgical oncological studies are conducted on the possibility of detection of sentinel nodes, which hinted at a lack of data and experience, a complicating factor is also relatively complicated lymphatic drainage, body of the uterus. In terms of prevention, there are several ways to reduce the rising incidence of disease. In the context of primary prevention is the use of hormonal contraceptives. Also, women who use hormone replacement therapy, are detailed under medical supervision, which allows for early tumor states. Women with the accumulation of risk factors could benefit from simple diagnostic modalities (ie ultrasound, in particular), which in this case can be used for “limited screening”, resp. dispensary accurately high-risk patients. In primary prevention is the way the reduction of obesity. Research then turned to clarify the pathogenesis at the molecular level, the identification of new specific biomarkers that could help in early diagnosis and therapy. In the context of inherited disposition cancer of endometrium is then appropriate to focus on the relevant risk group of patients with accumulation of cancer of endometrium and colorectal cancer in a personal and family history, which are then indicated to the genetic consultation and possibly mutation analysis.

Key words:
cancer of endometrium, histological types, pathogenesis, risk factors, dissemination of tumor, therapy options.

Sources

1. Benedet, JL., et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynecol Obstet, 2000, 70, p. 207.

2. Burger, MP. Management of stage I endometrial carcinoma. BMJ. 2001, 322, 7286, p. 568-569.

3. Creasman, WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer, 71, 4, Suppl, 1993, p, 1467-1470.

4. DelMachio, A. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs. MRI. Amer J Roentgenol, 1993, 160, p. 533.

5. Gershenson, DM., McGuire, WP., et al. Gynecologic Cancer. Controversis in Management. Philadelphia: Elsevier Churchill Livingstone 2004, 1001 p.

6. Gurpide, E. Endometrial cancer: biochemical and clinical correlates. J Nat Cancer Institute. 1991, 83, 6, p. 405-416.

7. Hetzel, DJ., Wilson, TO., Keeney, GL., et al. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol, 1992, 47, 2, p. 179-185.

8. Holub, Z., et al. Comparison of two procedures for sentinel lymph node detection in patiens with endometrial cancer: result of a pilot study. Eur J Gynec Oncol, 2002, 23, p. 53.

9. Homesley, HD., Zaino, R. Endometrial cancer: prognostic factors. Seminars in Oncology. 1994, 21, 1, p. 71-78.

10. Chovanec, J., Rašovská, O. Maligní nádory endometria. In: Adam, Z., Vorlíček, J., Vaníček, J. Diagnostické a léčebné postupy u maligních chorob. Praha: Grada, 2002, s. 223-232.

11. Kolář, Z., et al. Molekulární patologie nádorů. Olomouc: Epava, 2003, 168 s..

12. Kucera, E. Accuracy of intraoperative frozen section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest, 2000, 49, p. 62.

13. Kucera, H., Michalova, W., Weghaupt, K. Efficiency of primary radiotherapy in generally locally inoperable carcinoma of the endometrium. Oster Z Onkol, 1977, 4, 1, p. 3-13.

14. Lacheta, J., Cibula, D., et al. Proteomics a jeho význam pro gynekologickou onkologii. Čes Gynek, 2004, 69, s. 384.

15. Lu, KH., Broaddus, RR. Gynecologic cancers in Lynch syndrome/HNPCC. Familial Cancer, 2005, 4, p. 249.

16. Lurain, JR. The significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol, 1992, 46, 2, p. 143-144.

17. Morrow, CP., Bundy, BN., Kurman, RJ., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecologic Oncology. 1991, 40, 1, p. 55-65.

18. Motlík, K., Živný, J. Patologie v ženském lékařství. Praha: Grada, 2001.

19. Munstedt, K., Grant, P., Woenckhaus, J., et al. Cancer of the endometrium: current aspects of diagnostics and treatement. World J Surg Oncol, 2004, 2, p. 24.

20. Novotný, J., et al. Klinická a radiační onkologie pro praxi. Praha: Triton, 2005, 185.

21. Novotvary 2003 ČR, 2006, ÚZIS ČR, NOR ČR.

22. Rob, L. Současné trendy v léčbě gynekologických nádorů. Gynek. po promoci. 2006, 2, p. 47.

23. Šlampa, P., et al. Radiační onkologie v praxi. Brno: MOÚ 2004, 2007, p. 93, 109.

24. Takeshima, Y., Tahala, N. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol. 1996, 88, 2, p. 280-282.

25. Viani, GA, Patia BF, Pellizzon AC., et al. High-risk surgical stage I endometrial cancer: analysis of treatement outcome. Radiat Oncol, 2006, 1, p.24.

26. Weiss, JM., Saltzmann, BS., et al. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Amer J Epidemiol, 2006, 165, p. 56.